PM

Prof. (Dr.) Sidharth Mehan

Also known as: Prof. (Dr.) Sidharth Mehan is working as Professor in Division of Neuroscience, Department of Pharmacology at ISF College of Pharmacy, Moga, Punjab, India, Affiliated to IK Gujral Punjab Technical University (IKGPTU), Jalandhar, Govt. of Punjab, India

ISF College of Pharmacy

ORCID iD 0000-0003-0034-835X
Follow

About

Prof. (Dr.) Sidharth Mehan, Ph.D., M.Pharm (Pharmacology), is a distinguished professor in the Division of Neuroscience within the Department of Pharmacology at ISF College of Pharmacy, Moga, Punjab, India. This institution is recognized as one of the country's premier centers for pharmaceutical education and research. Dr. Mehan brings over 16 years of academic, research, and administrative expertise to his role.

Research Grants & Funding:

- Dr. Mehan was awarded various significant grants from the Indian government. The first grant was for excellence in idea innovation from the Ministry of Micro, Small & Medium Enterprises (MSME), Government of India, amounting to INR 18.5 lakh.
- The second grant, valued at INR 37 lakh, was awarded by the Department of Science & Technology (DST-SERB CRG) for core research in diagnosing and preventing motor neuron diseases.
- In the past five years, Dr. Mehan's lab has undertaken eleven ongoing national and international research consultancies, with a total cost exceeding ONE CRORE.
- He has published over 151 research and review articles in reputable international journals.
- Dr. Mehan’s research spans translational neuroscience, pharmacology, molecular neurobiology, and drug discovery. His compelling presentations at national and international conferences underscore his proficiency in communication and oratory skills.
- To date, he has supervised 71 M.Pharm research projects and four doctoral theses. Additionally, he has been engaged in animal welfare and social initiatives for 17 years. Dr. Mehan has received numerous awards for his research papers at national and international conferences.
- He contributes as a member or leader in various national and international pharmaceutical and clinical therapeutic committees. He serves as an editor and editorial board reviewer for several reputed journals and magazines. Dr. Mehan is also the author of various international book chapters.

Career Objective:

Dr. Mehan aspires to secure a challenging and responsible position in pharmacology and molecular biotechnology research. He aims to foster creativity and innovation while working towards achieving organizational goals and enhancing his professional skills and knowledge.

Areas of Interest and Expertise:

- Dr. Mehan specializes in translational neuroscience, cellular and molecular neuropharmacology, and drug discovery. He is particularly focused on identifying diagnostic biomarkers for neurodegenerative disorders and developing drug discovery screening procedures. His research aims to establish and validate therapeutic strategies for conditions including Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Autism, Brain Hemorrhage, Alzheimer’s Disease, Huntington’s Disease, Obsessive-Compulsive Disorder, and Bipolar Disorder.

Notable Academic Work:

- M.Pharm Thesis: "Role of p38MAPK Inhibitor in ICV-STZ Induced Alzheimer’s Disease"
- Ph.D. Thesis: "Investigation of Possible Protective Strategies for Intracerebroventricular Streptozotocin (ICV-STZ) Induced Alzheimer’s Type Dementia Associated with Novel Molecular Targets." This research is cited in United States Patent: US 9,567,384 B2.

Patent Information:
For more information on Dr. Mehan's patented research, you can access the patent document:
https://patentimages.storage.googleapis.com/b2/ca/c2/0526fd8e46bb9b/US9567384.pdf

Current Research Highlights:

- Dr. Mehan is actively involved in developing drug discovery screening procedures and establishing and validating therapeutic strategies for diseases such as Motor Neuron Diseases (multiple sclerosis and amyotrophic lateral sclerosis), Autism, Brain Hemorrhage, OCD, Bipolar Disorders, Traumatic Brain Injury, Alzheimer’s,, Huntington’s and Parkinson’s Disease.
- His current research focuses on targets such as Neurogenesis, Sonic Hedgehog (Shh); Klotho, ERK/c-JNK/p38MAPK; JAK-STAT/PI3K/Akt/mTOR; SIRT-1/Keap1/Nrf2/HO-1; GLP-1/IGF-1; PPAR-ϒ; BDNF, p75NTR, NMDA, TRKB/AC/cAMP/CREB/PKA; BACE-1/Gamma-Secretase; GDNF/GFRA1/RET/GSK3beta and neuronal mitochondria (CoQ10, ETC-Complexes I-V).

Employment

  • ISF College of Pharmacy Professor
    2009 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (209)